Addex Therapeutics (ADXN) Price to Book (2020 - 2026)

Addex Therapeutics has disclosed Price to Book across 7 years of filings, most recently posting 1.34 for Q1 2026.

• In Q1 2026, Price to Book rose 106.17% year-over-year to 1.34; the TTM figure through Mar 2026 stood at 1.34 (up 106.17% YoY), while the FY2025 annual figure was 1.2, up 130.92% from the prior year.
• Price to Book came in at 1.34 for Q1 2026 at Addex Therapeutics, up from 1.16 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 45.75 in Q1 2022 to a low of 5.04 in Q1 2024.
• Average Price to Book over 5 years is 9.3, with a median of 1.34 recorded in 2026.
• Year-over-year, Price to Book slumped 115.56% in 2024 and jumped 142.71% in 2025.
• Over 5 years, Price to Book stood at 18.61 in 2022, then tumbled by 84.41% to 2.9 in 2023, then tumbled by 82.14% to 0.52 in 2024, then jumped by 123.56% to 1.16 in 2025, then gained by 15.78% to 1.34 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 1.34 in Q1 2026, 1.16 in Q4 2025, and 1.04 in Q3 2025.